Skip to main content
Log in

Ceraflex versus Amplatzer occluder for secundum atrial septal defect closure

Multicenter clinical experience

Ceraflex™- vs. Amplatzer™-Occluder zum Verschluss eines Vorhofseptumdefekts vom Sekundumtyp

Klinische Multizenterstudie

  • Original article
  • Published:
Herz Aims and scope Submit manuscript

Abstract

Aim

The Ceraflex atrial septal defect occluder is an alternative device to the Amplatzer septal occluder with some structural innovations including flexible connection, increased flexibility, and minimized amount of implant material. We evaluated the efficiency and safety of the Ceraflex septal occluder device in percutaneous closure of secundum atrial septal defects.

Patients and methods

This was a prospective, nonrandomized, multicenter study of patients undergoing transcatheter closure for an atrial septal defect with the Ceraflex and the Amplatzer septal occluder devices. A clinical evaluation and follow-up transthoracic echocardiography were performed at 1, 6, and 12 months.

Results

Between 2010 and 2014, 125 patients underwent atrial septal defect closure with the Ceraflex septal occluder (n = 58) and the Amplatzer septal occluder (n = 67) under transesophageal echocardiography guidance. Patient characteristics, the stretched size of the defect, device size, and fluoroscopy time were similar between the groups. The immediate and follow-up complete occlusion rates for both groups were 100%. There was no device embolization, procedure-related stroke, or pericardial effusion.

Conclusions

The Ceraflex septal occluder is a safe and efficient device for closure of secundum atrial septal defects with no procedural complications. The Ceraflex has similar outcomes when compared with the Amplatzer septal occluder device. The advantage of the Ceraflex septal occluder device is that it can be deployed without the tension of the delivery catheter.

Zusammenfassung

Ziel

Der Ceraflex™-Occluder zum Verschluss eines Vorhofseptumdefekts stellt ein alternatives System zum Amplatzer™-Occluder dar, das mit einigen strukturellen Innovationen einschließlich einer flexiblen Verbindung, erhöhten Flexibilität und Minimierung der Menge implantierten Materials einhergeht. Untersucht wurde die Wirksamkeit und Sicherheit des Ceraflex™-Occluders bei perkutanem Verschluss von Vorhofseptumdefekten vom Sekundumtyp.

Methoden

Es handelte sich um eine prospektive, nichtrandomisierte Multizenterstudie an Patienten mit Verschluss eines Vorhofseptumdefekts mittels eines Katheters, und zwar dem Ceraflex™- oder dem Amplatzer™-Occluder. Nach 1, 6 und 12 Monaten erfolgten bei den Patienten mit Vorhofseptumdefekt eine klinische Untersuchung und eine transthorakale Nachsorgeechokardiographie.

Ergebnisse

Zwischen 2010 und 2014 wurde bei 125 Patienten der Verschluss eines Vorhofseptumdefekts mit dem Ceraflex™-Occluder (n = 58) bzw. dem Amplatzer™-Occluder (n = 67) unter transösophagealer Steuerung durchgeführt. Patientenmerkmale, Defektgröße unter Dehnung, Größe des Occluders und Durchleuchtungsdauer waren in beiden Gruppen ähnlich. Die vollständige Verschlussrate lag unmittelbar nach dem Eingriff und im Verlauf für beide Gruppen bei 100%. Es gab keine Occluderembolie, interventionsbedingten Schlaganfälle oder Perikardergüsse.

Schlussfolgerungen

Der Ceraflex™-Occluder ist ein sicheres und wirksames System zum Verschluss eines Vorhofseptumdefekts vom Sekundumtyp ohne interventionsbedingte Komplikationen. Für den Ceraflex™-Occluder liegen ähnliche Ergebnisse vor wie für den Amplatzer™-Occluder. Der Vorteil des Ceraflec™-Occluders liegt darin, dass er eingesetzt wird, ohne dass der Platzierungskatheter Zug daran ausübt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Abbreviations

ASD:

Atrial septal defect

ASO:

Amplatzer septal occluder

CSO:

Ceraflex septal occluder

PET:

Polyethylene terephthalate

TEE:

Transesophageal echocardiography

TTE:

Transthoracic echocardiography

References

  1. King TD, Thompson SL, Steiner C, Mills NL (1976) Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 235:2506–2509

    Article  CAS  PubMed  Google Scholar 

  2. Prieto LR, Foreman CK, Cheatham JP, Latson LA (1996) Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal Umbrella. Am J Cardiol 78:1310–1312

    Article  CAS  PubMed  Google Scholar 

  3. Rickers C, Hamm C, Stern H et al (1998) Percutaneous closure of secundum atrial septal defect with a new self centering device (“angel wings”). Heart 80:517–521

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Rome JJ, Keane JF, Perry SB et al (1990) Double-umbrella closure of atrial defects. Initial clinical applications. Circulation 82:751–758

    Article  CAS  PubMed  Google Scholar 

  5. İlkay E, Kaçmaz F, Özeke Ö et al (2010) The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: initial clinical experience. Turk Kardiyol Dern Ars 38:189–193

    PubMed  Google Scholar 

  6. Berger F, Ewert P, Bjornstad PG et al (1999) Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with Amplatzer septal occluder. Cardiol Young 9:468–473

    CAS  PubMed  Google Scholar 

  7. Chan KC, Godman MJ, Walsh K et al (1999) Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc (Amplatzer septal occluder): Multicenter UK experience. Heart 82:100–106

    Article  Google Scholar 

  8. Zhang DY, Zeng WJ, Zi ZJ, Chu PK (2009) Fabrication of graded TiN coatings on nitinol occluders and effects on in vivo nickel release. Mater Sci Eng C 1599–1603

  9. Wang JK, Tsai SK, Lin SM et al (2008) Transcatheter closure of atrial septal defect without balloon sizing. Catheter Cardiovasc Interv 71:214–221

    Article  PubMed  Google Scholar 

  10. Zanchetta M (2004) On-line intracardiac echocardiography alone for Amplatzer Septal Occluder selection and device deployment in adult patients with atrial septal defect. Int J Cardiol 95:61–68

    Article  CAS  PubMed  Google Scholar 

  11. Du ZD, Hijazi ZM, Kleinman CS et al (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 39:1836–1844

    Article  PubMed  Google Scholar 

  12. Patel A, Lopez K, Banerjee A et al (2007) Transcatheter closure of atrial septal defects in adults > or = 40 years of age: immediate and followup results. J Interv Cardiol 20:82–88

    Article  PubMed  Google Scholar 

  13. Spies C, Timmermanns I, Schräder R (2007) Transcatheter closure of secundum atrial septal defects in adults with the Amplatzer septal occluder: intermediate and longterm results. Clin Res Cardiol 96:340–346

    Article  PubMed  Google Scholar 

  14. Masura J, Gavora P, Podnar T (2005) Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 45:505–507

    Article  PubMed  Google Scholar 

  15. Suda K, Raboisson MJ, Piette E et al (2004) Reversible atrioventricular block associated with closure of atrial septal defects using the Amplatzer device. J Am Coll Cardiol 43:1677–1682

    Article  PubMed  Google Scholar 

  16. Chessa M, Carminati M, Butera G et al (2002) Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 39:1061–1065

    Article  PubMed  Google Scholar 

  17. Levi DS, Moore JW (2004) Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 61:543–547

    Article  PubMed  Google Scholar 

  18. Amin Z, Hijazi ZM, Bass JL et al (2004) Erosion of Amplatzer septal occlude device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 63:496–502

    Article  PubMed  Google Scholar 

Download references

Compliance with ethical guidelines

Conflict of interest. M.A. Astarcioglu, M. Kalcik, T. Sen, A.C. Aykan, T. Gokdeniz, O.M. Gursoy, S. Karakoyun, S. Kulahcioglu, S. Gunduz, C. Kilit, M. Oylumlu, and B. Amasyali state that there are no conflicts of interest. The accompanying manuscript does not include studies on humans or animals.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M.A. Astarcioglu MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Astarcioglu, M., Kalcik, M., Sen, T. et al. Ceraflex versus Amplatzer occluder for secundum atrial septal defect closure. Herz 40 (Suppl 2), 146–150 (2015). https://doi.org/10.1007/s00059-014-4192-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-014-4192-0

Keywords

Schlüsselwörter

Navigation